AAAAAA
Results:
1-18
|
Results: 18
Authors:
Lawrence, JA
Adamson, PC
Caruso, R
Chow, C
Kleiner, D
Murphy, RF
Venzon, DJ
Shovlin, M
Noone, M
Merino, M
Cowan, KH
Kaiser, M
O'Shaughnessy, J
Zujewski, JA
Citation: Ja. Lawrence et al., Phase clinical trial of alitretinoin and tamoxifen in breast cancer patients: Toxicity, pharmacokinetic, and biomarker evaluations, J CL ONCOL, 19(10), 2001, pp. 2754-2763
Authors:
Fetsch, PA
Cowan, KH
Weng, DE
Freifield, A
Filie, AC
Abati, A
Citation: Pa. Fetsch et al., Detection of circulating tumor cells and micrometastases in stage II, III,and IV breast cancer patients utilizing cytology and immunocytochemistry, DIAGN CYTOP, 22(5), 2000, pp. 323-328
Authors:
Kim, M
Katayose, Y
Rojanala, L
Shah, S
Sgagias, M
Jang, L
Jung, YJ
Lee, SH
Hwang, SG
Cowan, KH
Citation: M. Kim et al., Induction of apoptosis in p16(INK4A) mutant cell lines by adenovirus-mediated overexpression of p16(INK4A) protein, CELL DEAT D, 7(8), 2000, pp. 706-711
Authors:
Vandier, D
Rixe, O
Besnard, F
Kim, M
Rikiyama, T
Goldsmith, M
Brenner, M
Gouyette, A
Cowan, KH
Citation: D. Vandier et al., Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter, CANC GENE T, 7(8), 2000, pp. 1120-1126
Authors:
Paul, D
Qazilbash, MH
Song, KM
Xu, H
Sinha, BK
Liu, J
Cowan, KH
Citation: D. Paul et al., Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12), CANC GENE T, 7(2), 2000, pp. 308-315
Authors:
Zujewski, J
Horak, ID
Bol, CJ
Woestenborghs, R
Bowden, C
End, DW
Piotrovsky, VK
Chiao, J
Belly, RT
Todd, A
Kopp, WC
Kohler, DR
Chow, C
Noone, M
Hakim, FT
Larkin, G
Gress, RE
Nussenblatt, RB
Kremer, AB
Cowan, KH
Citation: J. Zujewski et al., Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer, J CL ONCOL, 18(4), 2000, pp. 927-941
Authors:
Conley, B
O'Shaughnessy, J
Prindiville, S
Lawrence, J
Chow, C
Jones, E
Merino, MJ
Kaiser-Kupfer, MI
Caruso, RC
Podger, M
Goldspiel, B
Venzon, D
Danforth, D
Wu, SL
Noone, M
Goldstein, J
Cowan, KH
Zujewski, J
Citation: B. Conley et al., Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high riskfor developing invasive breast cancer, J CL ONCOL, 18(2), 2000, pp. 275-283
Authors:
MacLachlan, TK
Somasundaram, K
Sgagias, M
Shifman, Y
Muschel, RJ
Cowan, KH
El-Deiry, WS
Citation: Tk. Maclachlan et al., BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression, J BIOL CHEM, 275(4), 2000, pp. 2777-2785
Authors:
Rakkar, ANS
Katayose, Y
Kim, M
Craig, C
Ohri, E
Li, ZQ
Cowan, KH
Seth, P
Citation: Ans. Rakkar et al., A novel adenoviral vector expressing human Fas/CD95/APO-1 enhances p53-mediated apoptosis, CELL DEAT D, 6(4), 1999, pp. 326-333
Authors:
Cowan, KH
Moscow, JA
Huang, H
Zujewski, JA
O'Shaughnessy, J
Sorrentino, B
Hines, K
Carter, C
Schneider, E
Cusack, G
Noone, M
Dunbar, C
Steinberg, S
Wilson, W
Goldspiel, B
Read, EJ
Leitman, SF
McDonagh, K
Chow, C
Abati, A
Chiang, Y
Chang, YN
Gottesman, MM
Pastan, I
Nienhuis, A
Citation: Kh. Cowan et al., Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing themultidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients, CLIN CANC R, 5(7), 1999, pp. 1619-1628
Authors:
Song, KM
Cowan, KH
Sinha, BK
Citation: Km. Song et al., In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts, ONCOL RES, 11(3), 1999, pp. 153-159
Authors:
Somasundaram, K
MacLachlan, TK
Burns, TF
Sgagias, M
Cowan, KH
Weber, BL
El-Deiry, WS
Citation: K. Somasundaram et al., BRCA1 signals ARF-dependent stabilization and coactivation of p53, ONCOGENE, 18(47), 1999, pp. 6605-6614
Authors:
Gong, MK
Cowan, KH
Gudas, J
Moscow, JA
Citation: Mk. Gong et al., Isolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1), GENE, 233(1-2), 1999, pp. 21-31
Authors:
Zujewski, J
Pai, L
Wakefield, L
Giusti, R
Dorr, FA
Flanders, C
Caruso, R
Kaiser, M
Goodman, L
Merino, M
Gossard, M
Noone, MA
Denicoff, A
Venzon, D
Cowan, KH
O'Shaughnessy, JA
Citation: J. Zujewski et al., Tamoxifen and fenretinide in women with metastatic breast cancer, BREAST CANC, 57(3), 1999, pp. 277-283
Authors:
Moscow, JA
Huang, H
Carter, C
Hines, K
Zujewski, J
Cusack, G
Chow, C
Venzon, D
Sorrentino, B
Chiang, YW
Goldspiel, B
Leitman, S
Read, EJ
Abati, A
Gottesman, MM
Pastan, I
Sellers, S
Dunbar, C
Cowan, KH
Citation: Ja. Moscow et al., Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy, BLOOD, 94(1), 1999, pp. 52-61
Authors:
Paul, D
Cowan, KH
Citation: D. Paul et Kh. Cowan, Drug resistance in breast cancer, CONT CANC R, 3, 1999, pp. 481-517
Authors:
Rakkar, ANS
Li, ZW
Katayose, Y
Kim, M
Cowan, KH
Seth, P
Citation: Ans. Rakkar et al., Adenoviral expression of the cyclin-dependent kinase inhibitor p27(Kip1): a strategy for breast cancer gene therapy, J NAT CANC, 90(23), 1998, pp. 1836-1838
Authors:
Kim, M
Katayose, Y
Li, QD
Rakkar, ANS
Li, ZW
Hwang, SG
Katayose, D
Trepel, J
Cowan, KH
Seth, P
Citation: M. Kim et al., Recombinant adenovirus expressing Von Hippel-Lindau-mediated cell cycle arrest is associated with the induction of cyclin-dependent kinase inhibitor p27(Kip1), BIOC BIOP R, 253(3), 1998, pp. 672-677
Risultati:
1-18
|